Stay updated on Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial page
- Check5 days agoChange DetectedA new site revision tag 'Revision: v3.5.3' has been added to the page, indicating the current build version of the interface (replacing the previous v3.5.2).SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page now shows Revision: v3.5.2, replacing the previous v3.5.0.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedUpdated location label from Napoli, Italy, 80131 to Naples, Italy, 80131 in the study locations.SummaryDifference0.1%

- Check48 days agoChange DetectedThe site’s revision history now shows Revision: v3.5.0 added and Revision: v3.4.3 removed.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision: v3.4.3 is now displayed on the page, replacing Revision: v3.4.2.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision: v3.4.2 was added and the funding-status notice was removed, representing a minor site maintenance update that does not affect the trial details or user actions on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial page.